Real Estate / REIT - Healthcare FacilitiesNYSE
$35.18
-0.86 (-2.39%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 100% · confianza 20%
FCF escenarios
weak_data · normalized FCF n/d · quality 12.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
18/100
F
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$506M
P/E
N/A
•EV/EBITDA
13.5x
↑ROE
-1.1%
↓Gross Margin
77.9%
↑Debt/Equity
1.31
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2012–2025 · 13 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
-5.5%
FCF / Net income
1.38x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $147.7M · net income $-5.8M · FCF $-8.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||
| Revenue | $147.7M | $147.7M | $138.4M | $140.9M | $137.2M | $115.9M | $93.7M | $70.7M | $53.2M | $30.3M | $8.2M | $2.1M | — | $0.00 | — |
| Net Income | $-5.8M | $-5.8M | $6.6M | $20.6M | $19.1M | $18.3M | $-2.5M | $9.6M | $14.6M | $-87000.00 | $-6.4M | $-1.6M | — | $-95905.00 | $-50108.00 |
| EBITDA | $83.9M | $83.9M | $91.5M | $111.6M | $102.9M | — | — | — | — | — | — | — | — | — | — |
| EPS | -0.91 | -0.91 | 0.05 | 1.15 | 1.00 | 0.95 | -0.85 | 0.50 | — | — | — | — | — | — | — |
| Gross Margin | 77.9% | 77.9% | 78.9% | 80.1% | 81.6% | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | 24.4% | 24.4% | 23.6% | 26.9% | 28.2% | — | — | — | — | — | — | — | — | — | — |
| Net Margin | -4.0% | -4.0% | 4.8% | 14.6% | 14.0% | 15.8% | -2.7% | 13.6% | 27.4% | -0.3% | -77.4% | -78.0% | — | — | — |
| Balance Sheet | |||||||||||||||
| Debt/Equity | 1.31 | 1.31 | 1.22 | 1.06 | 1.10 | — | — | — | — | — | — | — | — | — | — |
| Current Ratio | 0.99 | 0.99 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||
| Free Cash Flow | $-8.1M | $-8.1M | $-25.1M | $58.4M | $-79.7M | — | — | — | — | — | — | $-32.0M | — | — | — |
| Returns | |||||||||||||||
| ROE | -1.1% | -1.1% | 1.2% | 3.5% | 3.0% | 2.9% | -0.6% | 2.2% | 5.4% | -0.0% | -4.1% | 1160.8% | — | 603.0% | -1130.3% |
| Valuation | |||||||||||||||
| P/E | — | — | 766.00 | 46.43 | 49.50 | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 13.45 | 13.45 | 12.59 | 11.80 | 13.03 | — | — | — | — | — | — | — | — | — | — |
| P/B | 0.92 | 0.92 | 0.95 | 1.20 | 1.02 | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | |||||||||||||||
| Revenue Growth | 6.7% | 6.7% | -1.8% | 2.7% | — | 23.7% | 32.5% | 33.0% | 75.3% | 269.6% | 298.2% | — | — | — | — |
| EPS Growth | -1920.0% | -1920.0% | -95.7% | 15.0% | — | 211.8% | -270.0% | — | — | — | — | — | — | — | — |
| Dividend Yield | 16.3% | 16.3% | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+26.9%
Start / end P/E
n/dx → n/dx
EPS bridge
0.05 → -0.91
Residual
+10.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.